All Stories

India's Aspen Biopharma Labs hit with FDA warning lette...

Aspen Biopharma Labs was hit with a warning letter from the FDA outlining multip...

ATyr hires ex-ChemoCentryx commercial chief for planned...

ATyr Pharma is stepping up its preparations to launch a steroid-sparing drug wit...

J&J combo signals new era in EGFR lung cancer with surv...

J&J has the most convincing data that its combination of Rybrevant and Lazcluze ...

J&J combo signals new era in EGFR lung cancer with surv...

J&J has the most convincing data that its combination of Rybrevant and Lazcluze ...

To approve Exelixis' Cabometyx in neuroendocrine tumors...

The FDA has approved Exelixis’ Cabometyx for neuroendocrine tumors. In an intere...

Roche’s Ocrevus, Novartis’ Kesimpta set to lead CNS mar...

The global market for central nervous system therapies is on track to log its hi...

Senate confirms Johns Hopkins surgeon Marty Makary to l...

Late Tuesday, the Senate confirmed Johns Hopkins surgeon Marty Makary, M.D., as ...

#FierceMadness: Heavyweights face off in Elite Eight ro...

As the college basketball March Madness tournament gets underway, so too does Fi...

Eyeing blockbuster sales, Harmony names Takeda veteran ...

Harmony Biosciences has named Adam Zaeske its chief commercial officer, luring t...

GSK ushers in new UTI antibiotic with FDA nod for first...

The company's Blujepa is the first in a new class of oral antibiotics for UTIs i...

Axsome touts success of phase 3 trial of Sunosi in ADHD...

Fast-rising New York City central nervous system specialist Axsome has scored in...

Eisai lays out road map to blockbuster sales projection...

Eisai ran a simulation projecting that Leqembi sales for fiscal year 2027, which...

Contractors WuXi Bio, WuXi XDC eye continued growth aft...

Shortly after WuXi AppTec offered an upbeat outlook for 2025, other WuXi compani...

Trump again threatens tariffs on pharmaceuticals in 'no...

After threatening a month ago to impose “25% or higher” tariffs on foreign-made ...

AstraZeneca, Pfizer rebuked over breaking UK drug marke...

The PMCPA has dug into the industry’s LinkedIn activities once again. AstraZenec...

Eyeing blockbuster sales, Harmony names Takeda veteran ...

Harmony Biosciences has named Adam Zaeske its chief commercial officer, luring t...

Gavi terminates COVID vaccine deal with Clover, demands...

International vaccine partnership Gavi has discontinued a COVID vaccine advance ...

After Starboard Value gets a seat on the board, another...

TOMS Capital Investment Management picked up a stake at the consumer health drug...

Bharat Biotech enters cell and gene therapy market with...

Bharat Biotech is pumping $75 million into a new cell and gene therapy manufactu...

Novo Nordisk offers cheaper Wegovy for all cash-paying ...

Novo Nordisk has quickly expanded its discounted Wegovy program, now offering al...

Biogen plots 2028 headquarters shift to new 'innovation...

Biogen on Monday said it signed a 15-year lease for a building at Cambridge’s Ke...

The Service Edge: The Key to Unlocking the Full Potenti...

Biopharma moves fast—your data solutions provider should too. Learn how excellen...

Rethinking Direct-to-Consumer Audiences: The Case for A...

Generate up to 6x more script lift. An adaptive, dynamic approach optimizes DTC ...

Revolutionizing Patient Marketing: How PatientPoint Pre...

PatientPoint Precision is reshaping patient marketing by combining EHR data with...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.